These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8049700)

  • 21. Effect of one-year subcutaneous and sublingual immunotherapy on clinical and laboratory parameters in children with rhinitis and asthma: a randomized, placebo-controlled, double-blind, double-dummy study.
    Yukselen A; Kendirli SG; Yilmaz M; Altintas DU; Karakoc GB
    Int Arch Allergy Immunol; 2012; 157(3):288-98. PubMed ID: 22041501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Specific subcutaneous immunotherapy with recombinant grass pollen allergens: first randomized dose-ranging safety study.
    Klimek L; Schendzielorz P; Pinol R; Pfaar O
    Clin Exp Allergy; 2012 Jun; 42(6):936-45. PubMed ID: 22909165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Efficacy of immunotherapy in the treatment of asthma].
    Martín Muñoz MF
    Allergol Immunopathol (Madr); 2004; 32(3):133-41. PubMed ID: 15120030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study.
    Bufe A; Ziegler-Kirbach E; Stoeckmann E; Heidemann P; Gehlhar K; Holland-Letz T; Braun W
    Allergy; 2004 May; 59(5):498-504. PubMed ID: 15080830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients.
    Rossi RE; Monasterolo G
    Int Arch Allergy Immunol; 2004 Sep; 135(1):44-53. PubMed ID: 15286445
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A double-blind, multicenter immunotherapy trial in children, using a purified and standardized Cladosporium herbarum preparation. I. Clinical results.
    Dreborg S; Agrell B; Foucard T; Kjellman NI; Koivikko A; Nilsson S
    Allergy; 1986 Feb; 41(2):131-40. PubMed ID: 3518526
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Both sublingual and supralingual routes of administration are effective in long-term allergen-specific immunotherapy.
    Panzner P; Petráš M; Sýkora T; Lesná IK; Liška M
    Allergy Asthma Proc; 2011; 32(2):142-50. PubMed ID: 21439167
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnosis and immunotherapy of mould allergy. VI. IgE-mediated parameters during a one-year placebo-controlled study of immunotherapy with Cladosporium.
    Malling HJ; Dreborg S; Weeke B
    Allergy; 1987 May; 42(4):305-14. PubMed ID: 3303997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant allergen-based monitoring of antibody responses during injection grass pollen immunotherapy and after 5 years of discontinuation.
    Gadermaier E; Staikuniene J; Scheiblhofer S; Thalhamer J; Kundi M; Westritschnig K; Swoboda I; Flicker S; Valenta R
    Allergy; 2011 Sep; 66(9):1174-82. PubMed ID: 21480924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunotherapy with mosquito (Culex quinquefasciatus) extract: a double-blind, placebo-controlled study.
    Srivastava D; Singh BP; Sudha VT; Arora N; Gaur SN
    Ann Allergy Asthma Immunol; 2007 Sep; 99(3):273-80. PubMed ID: 17910332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical efficacy of microencapsulated timothy grass pollen extract in grass-allergic individuals.
    TePas EC; Hoyte EG; McIntire JJ; Umetsu DT
    Ann Allergy Asthma Immunol; 2004 Jan; 92(1):25-31. PubMed ID: 14756461
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of efficacy of immunotherapy in children with asthma monosensitized to Alternaria.
    Kiliç M; Altintaş DU; Yilmaz M; Bingöl-Karakoç G; Burgut R; Güneşer-Kendirli S
    Turk J Pediatr; 2011; 53(3):285-94. PubMed ID: 21980810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Short-term preseasonal immunotherapy: is early clinical efficacy related to the basophil response?
    Kepil Özdemir S; Sin BA; Güloğlu D; İkincioğulları A; Gençtürk Z; Mısırlıgil Z
    Int Arch Allergy Immunol; 2014; 164(3):237-45. PubMed ID: 25170594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis and immunotherapy of mould allergy. VII. IgG subclass response and relation to the clinical efficacy of immunotherapy with Cladosporium.
    Malling HJ; Djurup R
    Allergy; 1988 Jan; 43(1):60-70. PubMed ID: 3344936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunotherapy with a mass unit Parietaria judaica extract: a tolerance study with evidence of immunological changes to the major allergen Par j 1.
    García Villalmanzo I; Hernández MD; Campos A; Giner AM; Polo F; Cortés C; Basomba A
    J Investig Allergol Clin Immunol; 1999; 9(5):321-9. PubMed ID: 10582201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rush immunotherapy with sublingual administration of grass allergen extract.
    Feliziani V; Marfisi RM; Parmiani S
    Allergol Immunopathol (Madr); 1993; 21(5):173-8. PubMed ID: 8160561
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A double-blind, multicenter immunotherapy trial in children, using a purified and standardized Cladosporium herbarum preparation. II. In vitro results.
    Karlsson R; Agrell B; Dreborg S; Foucard T; Kjellman NI; Koivikko A; Einarsson R
    Allergy; 1986 Feb; 41(2):141-50. PubMed ID: 3518527
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnosis and immunotherapy of mould allergy. With special reference to Cladosporium herbarum.
    Malling HJ
    Dan Med Bull; 1990 Feb; 37(1):12-22. PubMed ID: 2178885
    [No Abstract]   [Full Text] [Related]  

  • 39. Safety and efficacy of specific immunotherapy with standardized allergenic extracts adsorbed on aluminium hydroxide.
    Wüthrich B; Gumowski PL; Fäh J; Hürlimann A; Deluze C; André C; Fadel R; Carat F
    J Investig Allergol Clin Immunol; 2001; 11(3):149-56. PubMed ID: 11831445
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sublingual immunotherapy abrogates seasonal bronchial hyperresponsiveness in children with Parietaria-induced respiratory allergy: a randomized controlled trial.
    Pajno GB; Passalacqua G; Vita D; Caminiti L; Parmiani S; Barberio G
    Allergy; 2004 Aug; 59(8):883-7. PubMed ID: 15230823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.